Investidor Profissional Gestao de Recursos Ltda. lowered its holdings in Danaher Co. (NYSE:DHR – Free Report) by 9.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,537 shares of the conglomerate’s stock after selling 277 shares during the period. Danaher makes up about 0.3% of Investidor Profissional Gestao de Recursos Ltda.’s portfolio, making the stock its 13th largest holding. Investidor Profissional Gestao de Recursos Ltda.’s holdings in Danaher were worth $582,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Kentucky Retirement Systems Insurance Trust Fund grew its position in Danaher by 11.6% during the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock worth $4,874,000 after buying an additional 2,202 shares in the last quarter. ORG Partners LLC grew its holdings in shares of Danaher by 1,212.8% during the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock worth $636,000 after purchasing an additional 2,559 shares in the last quarter. Generate Investment Management Ltd acquired a new position in Danaher in the fourth quarter valued at about $8,044,000. Compass Capital Management Inc. lifted its position in Danaher by 4.8% during the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate’s stock worth $54,615,000 after purchasing an additional 10,994 shares during the period. Finally, Channing Global Advisors LLC grew its stake in Danaher by 42.8% during the fourth quarter. Channing Global Advisors LLC now owns 5,666 shares of the conglomerate’s stock worth $1,301,000 after buying an additional 1,698 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insider Buying and Selling at Danaher
In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 11.10% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on DHR
Danaher Trading Down 8.3 %
DHR opened at $181.42 on Friday. The stock has a fifty day moving average price of $209.99 and a 200-day moving average price of $234.26. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a 12 month low of $181.20 and a 12 month high of $281.70. The firm has a market cap of $129.66 billion, a price-to-earnings ratio of 34.36, a PEG ratio of 2.66 and a beta of 0.86.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the firm posted $2.09 earnings per share. As a group, equities research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.
Danaher Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.71%. The ex-dividend date is Friday, March 28th. Danaher’s dividend payout ratio is presently 24.24%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- How to Use Stock Screeners to Find Stocks
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to invest in marijuana stocks in 7 steps
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Consumer Staples Stocks, Explained
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.